“The IG has given a green light for Slaoui to use his public office for self-enrichment, a practice that has become frighteningly common within the Trump administration.”
By Julia Conley, staff writer for Common Dreams. Published 7-15-2020
Ethics watchdogs on Wednesday slammed a ruling by the Health and Human Services Department’s inspector general, who decided this week that Moncef Slaoui, a former pharmaceutical executive now heading the Trump administration’s coronavirus vaccine task force, does not have to disclose or divest his investments in the industry.
As the co-director of Operation Warp Speed, a public-private partnership aimed at finding a vaccine for Covid-19 by the end of 2020, Slaoui is in the position to award contracts to pharmaceutical companies researching potential vaccines and treatments. Continue reading